Skip to content

Efficacy of a reduced-sodium salt substitute on blood pressure in hypertensive patients

Efficacy of a reduced-sodium salt substitute on blood pressure in hypertensive patients

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240722001
Enrollment
64
Registered
2024-07-22
Start date
2024-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients older than 40 years with a diagnosis of Essential or Primary Hypertension. Hypertension low sodium

Interventions

Use the low sodium products in every meal as recommended by the dietitian.,Adjust your behavior according to dietary advice from a dietitian.
Experimental Dietary Supplement,No Intervention Behavioral
Intervention group,control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients older than 40 years with a diagnosis of Essential or Primary Hypertension.

Exclusion criteria

Exclusion criteria: Have salt-losing nephropathy. Received drugs that affect sodium in the body, such as thiazide drugs, furosemide, etc. Patients with swelling due to high ECF causing low sodium. such as patients with heart failure, liver failure Patients with chronic kidney disease stage 3b (CKD stage3b) and above or GFR<45mL/min/1.73 squaremeter Patients with syndrome of inappropriate ADH secretion (SIADH). Participants who ate out more than once per week. Participants with food allergies to soybeans. Wheat and oysters Those who do not agree to act according to the doctor's advice in accordance with the research protocol. or have a physical mental disorder that affects the follow-up of the research study Patients diagnosed with Hypertensive urgency or Hypertensive emergency. Participants who cannot read Thai and cannot write letters.

Design outcomes

Primary

MeasureTime frame
Blood Pressure 1 week and 8 week Sphygmomanometer

Secondary

MeasureTime frame
24-h urine Na excretion 1 week and 8 week Laboratory Examination,food record 1 week and 8 week recall, record

Countries

Thailand

Contacts

Public ContactDr. Kanokkarn Chupisanyarote

Faculty of Medicine Thammasat University

kanokkarn.chu@gmail.com66841267838

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026